Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer

NCT06419673 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: Serplulimab
DRUG: Cisplatin
DRUG: Carboplatin
RADIATION: Brachytherapy and External Beam Radiotherapy

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences